Novel Drug Bests Interferon at Halting MS Activity

(MedPage Today) -- Nearly half of patients on ocrelizumab achieved no evidence of disease activity (NEDA)
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news
More News: General Medicine